Trends of Concomitant Diabetes and Peripheral Artery Disease and Lower Extremity Amputation in US Medicare Patients, 2007 to 2019.
amputation, surgical
epidemiology
ethnicity
peripheral artery disease
prevalence
Journal
Circulation. Cardiovascular quality and outcomes
ISSN: 1941-7705
Titre abrégé: Circ Cardiovasc Qual Outcomes
Pays: United States
ID NLM: 101489148
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
pmc-release:
20
06
2024
medline:
22
6
2023
pubmed:
20
6
2023
entrez:
20
6
2023
Statut:
ppublish
Résumé
Previous studies demonstrate geographic and racial/ethnic variation in diagnosis and complications of diabetes and peripheral artery disease (PAD). However, recent trends for patients diagnosed with both PAD and diabetes are lacking. We assessed the period prevalence of concurrent diabetes and PAD across the United States from 2007 to 2019 and regional and racial/ethnic variation in amputations among Medicare patients. Using Medicare claims from 2007 to 2019, we identified patients with both diabetes and PAD. We calculated period prevalence of concomitant diabetes and PAD and incident cases of diabetes and PAD for every year. Patients were followed to identify amputations, and results were stratified by race/ethnicity and hospital referral region. 9 410 785 patients with diabetes and PAD were identified (mean age, 72.8 [SD, 10.94] years; 58.6% women, 74.7% White, 13.2% Black, 7.3% Hispanic, 2.8% Asian/API, and 0.6% Native American). Period prevalence of diabetes and PAD was 23 per 1000 beneficiaries. We observed a 33% relative decrease in annual new diagnoses throughout the study. All racial/ethnic groups experienced a similar decline in new diagnoses. Black and Hispanic patients had on average a 50% greater rate of disease compared with White patients. One- and 5-year amputation rates remained stable at ≈1.5% and 3%, respectively. Native American, Black, and Hispanic patients were at greater risk of amputation compared with White patients at 1- and 5-year time points (5-year rate ratio range, 1.22-3.17). Across US regions, we observed differential amputation rates, with an inverse relationship between the prevalence of concomitant diabetes and PAD and overall amputation rates. Significant regional and racial/ethnic variation exists in the incidence of concomitant diabetes and PAD among Medicare patients. Black patients in areas with the lowest rates of PAD and diabetes are at disproportionally higher risk for amputation. Furthermore, areas with higher prevalence of PAD and diabetes have the lowest rates of amputation.
Sections du résumé
BACKGROUND
Previous studies demonstrate geographic and racial/ethnic variation in diagnosis and complications of diabetes and peripheral artery disease (PAD). However, recent trends for patients diagnosed with both PAD and diabetes are lacking. We assessed the period prevalence of concurrent diabetes and PAD across the United States from 2007 to 2019 and regional and racial/ethnic variation in amputations among Medicare patients.
METHODS
Using Medicare claims from 2007 to 2019, we identified patients with both diabetes and PAD. We calculated period prevalence of concomitant diabetes and PAD and incident cases of diabetes and PAD for every year. Patients were followed to identify amputations, and results were stratified by race/ethnicity and hospital referral region.
RESULTS
9 410 785 patients with diabetes and PAD were identified (mean age, 72.8 [SD, 10.94] years; 58.6% women, 74.7% White, 13.2% Black, 7.3% Hispanic, 2.8% Asian/API, and 0.6% Native American). Period prevalence of diabetes and PAD was 23 per 1000 beneficiaries. We observed a 33% relative decrease in annual new diagnoses throughout the study. All racial/ethnic groups experienced a similar decline in new diagnoses. Black and Hispanic patients had on average a 50% greater rate of disease compared with White patients. One- and 5-year amputation rates remained stable at ≈1.5% and 3%, respectively. Native American, Black, and Hispanic patients were at greater risk of amputation compared with White patients at 1- and 5-year time points (5-year rate ratio range, 1.22-3.17). Across US regions, we observed differential amputation rates, with an inverse relationship between the prevalence of concomitant diabetes and PAD and overall amputation rates.
CONCLUSIONS
Significant regional and racial/ethnic variation exists in the incidence of concomitant diabetes and PAD among Medicare patients. Black patients in areas with the lowest rates of PAD and diabetes are at disproportionally higher risk for amputation. Furthermore, areas with higher prevalence of PAD and diabetes have the lowest rates of amputation.
Identifiants
pubmed: 37339191
doi: 10.1161/CIRCOUTCOMES.122.009531
pmc: PMC10287062
mid: NIHMS1899865
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e009531Subventions
Organisme : American Heart Association-American Stroke Association
ID : 18SFRN33900147
Pays : United States
Références
Med Care. 2020 Jan;58(1):e1-e8
pubmed: 31688554
J Vasc Surg. 2009 Jul;50(1):54-60
pubmed: 19481407
J Vasc Surg. 2012 Dec;56(6):1663-8
pubmed: 22963815
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:128-35
pubmed: 26342129
JAMA. 2002 May 15;287(19):2570-81
pubmed: 12020339
Diabetes Care. 2016 Sep;39(9):1556-62
pubmed: 27555622
J Am Heart Assoc. 2018 Jan 12;7(2):
pubmed: 29330260
BMJ Surg Interv Health Technol. 2019 Jul;1(1):e000018
pubmed: 32309802
J Health Care Poor Underserved. 2018;29(2):782-800
pubmed: 29805140
JAMA. 2001 Sep 19;286(11):1317-24
pubmed: 11560536
Ann Vasc Surg. 2016 Jan;30:292-8.e1
pubmed: 26549811
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31
pubmed: 31862745
J Vasc Surg. 2016 May;63(5):1318-24
pubmed: 27005751
Diabetes Care. 1989 Jan;12(1):24-31
pubmed: 2714164
J Vasc Surg. 2019 Nov;70(5):1612-1619
pubmed: 31153696
JAMA. 2001 Oct 3;286(13):1599-606
pubmed: 11585483
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
Med Care. 2007 Dec;45(12):1210-5
pubmed: 18007172
Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):1808-1817
pubmed: 32580632
Atherosclerosis. 2018 Aug;275:379-381
pubmed: 29843915
CMAJ. 2019 Sep 3;191(35):E955-E961
pubmed: 31481423
J Am Coll Cardiol. 2012 Nov 20;60(21):2230-6
pubmed: 23103040
J Vasc Surg. 2011 Feb;53(2):330-9.e1
pubmed: 21163610
J Vasc Surg. 2016 Dec;64(6):1747-1755.e3
pubmed: 27670653
Circulation. 2009 Jan 6;119(1):123-30
pubmed: 19103988
J Am Coll Cardiol. 2018 Dec 25;72(25):3274-3284
pubmed: 30573030
Ann Vasc Surg. 2016 Jan;30:123-31
pubmed: 26169463